JoGH,O
2020,DATE
ISGH,O
The,O
role,O
of,O
children,O
in,O
transmission,O
of,O
Xue,PERSON
Li1,O
.,O
*,O
.,O
Wei,PERSON
Xu1,PERSON
.,O
*,O
.,O
Marshall,O
Dozier2,O
.,O
Yazhou,LOCATION
He1,O
.,O
Amir,PERSON
Kirolos1,O
.3,O
.,O
Evropi,MISC
on,O
behalf,O
of,O
UNCOVER,O
entre,O
for,O
Global,ORGANIZATION
Health,ORGANIZATION
.,O
Usher,TITLE
Edinburgh,O
.,O
UK,ORGANIZATION
College,ORGANIZATION
of,ORGANIZATION
Medicine,ORGANIZATION
and,O
Veterinary,O
Edinburgh,CITY
.,O
UK,COUNTRY
of,O
Infection,CAUSE_OF_DEATH
.,O
Veterinary,O
&,O
Ecologi,O
‐,O
cal,O
Liverpool,ORGANIZATION
.,O
UK,COUNTRY
Cancer,ORGANIZATION
Research,ORGANIZATION
UK,ORGANIZATION
Edinburgh,ORGANIZATION
Centre,ORGANIZATION
.,O
Medical,O
Research,ORGANIZATION
Council,ORGANIZATION
Edinburgh,ORGANIZATION
.,O
UK,COUNTRY
children,O
in,O
the,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
.,O
We,O
synthesized,O
evidence,O
for,O
four,NUMBER
categories,O
:,O
1,NUMBER
),O
stud,O
‐,O
ies,O
reporting,O
documented,O
cases,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
transmission,O
by,O
in,O
‐,O
fected,O
children,O
;,O
2,NUMBER
),O
studies,O
presenting,O
indirect,O
evidence,O
on,O
the,O
potential,O
estimating,O
the,O
proportions,O
of,O
children,O
infected,O
by,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
.,O
and,O
reported,O
results,O
narratively,O
.,O
Results,O
A,O
total,O
of,O
16,NUMBER
unique,O
studies,O
were,O
included,O
for,O
narrative,O
synthesis,O
.,O
There,O
is,O
limited,O
evidence,O
detailing,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
from,O
in,O
‐,O
fected,O
children,O
.,O
We,O
found,O
two,NUMBER
studies,O
that,O
reported,O
a,O
3,NUMBER
‐,O
month,DURATION
‐,O
old,O
whose,O
parents,O
developed,O
symptomatic,O
COVID,O
‐,O
19,NUMBER
seven,DURATION
days,DURATION
after,O
caring,O
for,O
the,O
infant,O
and,O
two,NUMBER
children,O
who,O
may,O
have,O
contracted,O
COVID,O
‐,O
19,NUMBER
from,O
the,O
initial,O
cases,O
at,O
a,O
indirect,O
evidence,O
on,O
the,O
po,O
‐,O
tential,O
for,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
transmission,O
by,O
children,O
.,O
three,NUMBER
of,O
which,O
found,O
prolonged,O
virus,O
shedding,O
in,O
stools,O
.,O
There,O
is,O
little,O
data,O
a,O
child,O
attending,O
classes,O
but,O
not,O
infecting,O
any,O
other,O
pupils,O
or,O
staff,O
.,O
Lastly,O
.,O
we,O
identified,O
six,NUMBER
studies,O
estimating,O
the,O
propor,O
‐,O
tion,O
of,O
children,O
infected,O
;,O
data,O
from,O
population,O
‐,O
based,O
studies,O
in,O
Iceland,COUNTRY
.,O
Italy,COUNTRY
.,O
South,COUNTRY
Korea,COUNTRY
.,O
Netherlands,COUNTRY
.,O
California,STATE_OR_PROVINCE
and,O
a,O
hospi,O
‐,O
tal,O
‐,O
based,O
study,O
in,O
the,O
UK,COUNTRY
suggest,O
children,O
may,O
be,O
less,O
likely,O
to,O
be,O
infected,O
.,O
studies,O
suggest,O
that,O
children,O
may,O
be,O
less,O
frequent,O
‐,O
ly,O
infected,O
or,O
infect,O
others,O
.,O
however,O
current,DATE
evidence,O
is,O
limit,O
‐,O
ed,O
.,O
Prolonged,O
faecal,O
shedding,O
observed,O
in,O
studies,O
highlights,O
the,O
potentially,O
increased,O
risk,O
of,O
faeco,O
‐,O
oral,O
transmission,O
in,O
chil,O
‐,O
dren,O
.,O
Further,O
seroprevalence,O
studies,O
(,O
powered,O
adequately,O
for,O
the,O
paediatric,O
population,O
),O
are,O
urgently,O
required,O
to,O
establish,O
whether,O
children,O
are,O
in,O
fact,O
less,O
likely,O
to,O
be,O
infected,O
compared,O
to,O
adults,O
.,O
Correspondence,O
to,O
:,O
Prof,TITLE
Evropi,O
Theodoratou,O
Centre,O
for,O
Global,O
Health,O
COVID,O
‐,O
19,NUMBER
.,O
caused,O
by,O
severe,O
acute,O
respiratory,O
syn,O
‐,O
drome,O
coronavirus,O
2,NUMBER
(,O
SARSCoV,O
‐,O
2,NUMBER
),O
.,O
was,O
declared,O
a,O
pandemic,O
on,O
11,NUMBER
March,DATE
2020,DATE
by,O
the,O
World,ORGANIZATION
Health,ORGANIZATION
Organization,ORGANIZATION
.,O
Children,O
are,O
less,O
likely,O
to,O
develop,O
severe,O
disease,CAUSE_OF_DEATH
from,O
COVID,O
‐,O
19,NUMBER
compared,O
to,O
adults,O
.,O
although,O
the,O
reasons,O
for,O
this,O
remain,O
unclear,O
[,O
1,NUMBER
],O
.,O
Despite,O
the,O
fewer,O
number,O
of,O
cases,O
reported,O
in,O
children,O
.,O
there,O
are,O
con,O
‐,O
cerns,O
about,O
asymptomatic,O
or,O
June,DATE
2020,DATE
Vol.,O
10,NUMBER
No.,O
1,NUMBER
011101,NUMBER
RE,O
‐,O
SEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
OF,O
COVID,O
‐,O
19,NUMBER
EVIDENCE,O
Electronic,O
supplementary,O
material,O
:,O
OF,O
COVID,O
‐,O
19,NUMBER
EVIDENCE,O
RESEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
Li,PERSON
et,O
al,O
.,O
mildly,O
symptomatic,O
paediatric,O
cases,O
go,O
‐,O
ing,O
undetected,O
and,O
unknowingly,O
transmitting,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
in,O
the,O
of,O
children,O
in,O
the,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
.,O
Literature,O
search,O
and,O
eligibility,O
criteria,O
We,O
searched,O
PubMed,O
.,O
medRxiv,O
and,O
the,O
WHO,O
COVID,O
‐,O
19,NUMBER
database,O
on,O
30,DATE
April,DATE
2020,DATE
with,O
entry,O
date,O
Document,O
),O
.,O
to,O
identify,O
studies,O
that,O
investigated,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
in,O
children,O
(,O
0,NUMBER
‐,O
18,DURATION
years,DURATION
),O
or,O
predefined,O
inclusion,O
and,O
exclusion,O
cri,O
‐,O
teria,O
.,O
We,O
hand,O
‐,O
searched,O
reference,O
lists,O
of,O
the,O
retrieved,O
eligible,O
publications,O
to,O
identify,O
any,O
additional,O
relevant,O
studies,O
.,O
In,O
par,O
‐,O
ticular,O
.,O
we,O
included,O
1,NUMBER
),O
studies,O
reporting,O
documented,O
COVID,O
‐,O
19,NUMBER
cases,O
transmitted,O
by,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
positive,O
children,O
;,O
2,NUMBER
),O
studies,O
presenting,O
indirect,O
evidence,O
on,O
the,O
potential,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
transmission,O
by,O
(,O
both,O
symptomatic,O
and,O
asymptomatic,O
),O
children,O
;,O
children,O
infected,O
by,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
.,O
Conversely,O
.,O
we,O
excluded,O
studies,O
investigating,O
clinical,O
features,O
and,O
/,O
or,O
We,O
restricted,O
studies,O
to,O
those,O
reported,O
in,O
English,NATIONALITY
or,O
Chinese,NATIONALITY
.,O
In,O
addition,O
.,O
we,O
summarized,O
and,O
checked,O
Data,O
extraction,O
and,O
evidence,O
synthesis,O
[,O
4.5,NUMBER
],O
;,O
six,NUMBER
studies,O
presenting,O
indirect,O
evidence,O
on,O
the,O
potential,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
transmission,O
by,O
children,O
June,DATE
2020,DATE
Vol.,O
10,NUMBER
No,O
.,O
1,NUMBER
011101,NUMBER
(,O
ie,O
.,O
proportion,O
of,O
children,O
infected,O
as,O
identified,O
through,O
random,O
or,O
targeted,O
population,O
testing,O
),O
and,O
we,O
also,O
report,O
results,O
from,O
a,O
large,O
hospital,O
‐,O
based,O
study,O
in,O
the,O
UK,COUNTRY
[,O
18,NUMBER
],O
.,O
Documented,O
cases,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
transmission,O
by,O
children,O
We,O
did,O
not,O
identify,O
any,O
stud,O
‐,O
ies,O
directly,O
addressing,O
the,O
transmission,O
dynamics,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
by,O
children,O
.,O
A,O
case,O
series,O
from,O
China,COUNTRY
described,O
10,NUMBER
paediatric,O
patients,O
admitted,O
to,O
a,O
childrens,O
hospital,O
in,O
China,COUNTRY
[,O
4,NUMBER
],O
.,O
They,O
identified,O
one,NUMBER
potential,O
case,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
transmission,O
from,O
an,O
infant,O
to,O
parents,O
.,O
who,O
subsequently,O
developed,O
symptomatic,O
COVID,O
‐,O
19,NUMBER
seven,DURATION
days,DURATION
after,O
looking,O
after,O
the,O
infant,O
.,O
This,O
is,O
prob,O
‐,O
ably,O
the,O
first,ORDINAL
piece,O
of,O
direct,O
evidence,O
indicating,O
children,O
as,O
a,O
source,O
of,O
adult,O
infection,CAUSE_OF_DEATH
.,O
contacts,O
(,O
735,NUMBER
students,O
and,O
128,NUMBER
staff,O
),O
of,O
18,NUMBER
initial,O
COVID,O
‐,O
19,NUMBER
cases,O
(,O
nine,NUMBER
students,O
and,O
nine,NUMBER
staff,O
),O
to,O
see,O
who,O
they,O
subsequently,O
infected,O
.,O
They,O
found,O
that,O
two,NUMBER
children,O
(,O
secondary,O
cases,O
),O
may,O
have,O
contracted,O
no,O
evidence,O
of,O
children,O
in,O
‐,O
fecting,O
teachers,O
or,O
staff,O
members,O
.,O
Indirect,O
evidence,O
of,O
the,O
po,O
‐,O
tential,O
for,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
transmission,O
by,O
children,O
One,NUMBER
study,O
as,O
‐,O
sessed,O
environmental,O
contamination,O
in,O
the,O
isolation,O
room,O
of,O
an,O
infected,O
infant,O
[,O
6,NUMBER
],O
.,O
Although,O
this,O
infant,O
was,O
asymptomatic,O
.,O
na,O
‐,O
sopharyngeal,O
swabs,O
confirmed,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
with,O
a,O
very,O
high,O
viral,O
load,O
.,O
The,O
presence,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
was,O
detected,O
on,O
the,O
sur,O
‐,O
faces,O
exposed,O
to,O
the,O
infant,O
(,O
eg,O
.,O
bedding,O
.,O
this,O
study,O
indicate,O
the,O
potential,O
risk,O
of,O
airborne,O
transmission,O
or,O
transmission,O
through,O
indirect,O
contact,O
of,O
hygiene,O
when,O
caring,O
for,O
infants,O
with,O
COVID,O
‐,O
19,NUMBER
.,O
Population,O
setting,O
.,O
patient,O
demographics,O
.,O
clinical,O
characteristics,O
Primary,O
results,O
Population,O
setting,O
:,O
Ten,NUMBER
patients,O
admitted,O
to,O
a,O
childrens,O
hospital,O
for,O
screening,O
based,O
on,O
presenta,O
‐,O
tion,O
with,O
acute,O
fever,CAUSE_OF_DEATH
and,O
or,O
respiratory,O
symptoms,O
AND,O
an,O
epidemi,O
‐,O
ological,O
link,O
to,O
an,O
adult,O
case,O
/,O
exposure,O
to,O
an,O
epidemic,O
area,O
.,O
De,O
‐,O
mographics,O
:,O
Age,O
:,O
3,NUMBER
‐,O
131,DURATION
months,DURATION
(,O
mean,O
:,O
74,DURATION
months,DURATION
),O
.,O
Gender,O
:,O
male,O
n,O
=,O
4,NUMBER
.,O
female,O
n,O
=,O
6,NUMBER
.,O
Clinical,O
characteristics,O
:,O
Presentation,O
:,O
Fever,CAUSE_OF_DEATH
n,O
=,O
8,NUMBER
(,O
80,PERCENT
%,PERCENT
),O
;,O
cough,O
n,O
=,O
6,NUMBER
(,O
60,PERCENT
%,PERCENT
),O
;,O
sore,O
throat,O
n,O
=,O
4,NUMBER
(,O
40,PERCENT
%,PERCENT
),O
;,O
stuffy,O
nose,O
n,O
=,O
3,NUMBER
(,O
30,PERCENT
%,PERCENT
),O
;,O
sneezing,O
and,O
rhinorrhoea,O
n,O
=,O
2,NUMBER
(,O
20,PERCENT
%,PERCENT
),O
.,O
RNA,O
(,O
mean,O
:,O
12,NUMBER
d,O
),O
after,O
illness,CAUSE_OF_DEATH
onset,O
.,O
and,O
9,NUMBER
staff,O
),O
18,NUMBER
individuals,O
(,O
9,NUMBER
students,O
and,O
9,NUMBER
staff,O
),O
from,O
15,NUMBER
and,O
128,NUMBER
staff,O
were,O
close,O
contacts,O
of,O
these,O
initial,O
cases,O
.,O
Confirmed,O
transmission,O
:,O
Transmission,O
from,O
infected,O
infant,O
to,O
adults,O
:,O
n,O
=,O
2,NUMBER
.,O
3,NUMBER
‐,O
mo,DURATION
‐,O
old,O
infant,O
whose,O
two,NUMBER
parents,O
developed,O
symptomatic,O
COVID,O
‐,O
19,NUMBER
seven,DURATION
days,DURATION
after,O
looking,O
after,O
the,O
infant,O
.,O
Source,O
of,O
infant,O
infection,CAUSE_OF_DEATH
not,O
reported,O
.,O
Infant,O
had,O
positive,O
nasopharyngeal,O
swabs,O
for,O
8,NUMBER
d.,O
National,O
Centre,O
for,O
Immunisation,ORGANIZATION
Research,ORGANIZATION
and,ORGANIZATION
Surveillance,ORGANIZATION
(,O
NCIRS,O
),O
[,O
5,NUMBER
],O
.,O
Australia,COUNTRY
De,O
‐,O
mographics,O
:,O
Not,O
reported,O
Clinical,O
characteristics,O
:,O
Not,O
reported,O
Mean,O
time,O
to,O
transmission,O
/,O
symptoms,O
onset,O
:,O
Not,O
reported,O
.,O
Parents,O
developed,O
symptomatic,O
COVID,O
‐,O
19,NUMBER
seven,DURATION
days,DURATION
after,O
looking,O
after,O
the,O
infant,O
.,O
Confirmed,O
transmission,O
:,O
Transmission,O
from,O
infected,O
stu,O
‐,O
dents,O
/,O
staff,O
to,O
students,O
:,O
n,O
=,O
2,NUMBER
.,O
No,O
confirmed,O
transmission,O
from,O
students,O
to,O
staff,O
.,O
One,NUMBER
secondary,O
a,O
staff,O
member,O
(,O
teacher,TITLE
),O
who,O
was,O
a,O
case,O
.,O
Mean,O
time,O
to,O
transmission,O
/,O
symptoms,O
onset,O
:,O
One,NUMBER
of,O
them,O
was,O
diagnosed,O
by,O
nose,O
/,O
throat,O
swab,O
testing,O
5,NUMBER
‐,O
10,DURATION
days,DURATION
after,O
the,O
last,O
contact,O
and,O
one,NUMBER
had,O
a,O
positive,O
antibody,O
test,O
4,DURATION
weeks,DURATION
after,O
their,O
exposure,O
.,O
June,DATE
2020,DATE
Vol.,O
10,NUMBER
No.,O
1,NUMBER
011101,NUMBER
RESEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
OF,O
COVID,O
‐,O
19,NUMBER
EVIDENCE,O
Children,O
and,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
OF,O
COVID,O
‐,O
19,NUMBER
EVIDENCE,O
RESEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
RE,O
‐,O
VIEWS,O
Li,O
et,O
al,O
.,O
Yung,PERSON
[,O
6,NUMBER
],O
.,O
Singapore,ORGANIZATION
Service,ORGANIZATION
.,O
KK,LOCATION
Women,O
’s,O
and,O
Children,O
’s,O
Population,O
setting,O
:,O
A,O
6,DURATION
month,DURATION
‐,O
old,O
infant,O
was,O
admitted,O
for,O
isolation,O
because,O
both,O
parents,O
tested,O
positive,O
for,O
COVID,O
‐,O
19,NUMBER
.,O
On,O
admission,O
.,O
infant,O
was,O
asymptomatic,O
.,O
but,O
nasopharyngeal,O
swabs,O
confirmed,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
with,O
very,O
high,O
viral,O
load,O
.,O
Con,O
‐,O
firmed,O
transmission,O
:,O
On,O
day,DURATION
2,NUMBER
of,O
admission,O
.,O
the,O
infant,O
’s,O
isola,O
‐,O
tion,O
environment,O
and,O
the,O
personal,O
protective,O
equipment,O
(,O
PPE,O
),O
of,O
a,O
health,O
care,O
worker,O
(,O
HCW,O
),O
who,O
was,O
looking,O
after,O
the,O
infant,O
were,O
sampled,O
.,O
For,O
the,O
infant,O
.,O
Ct,O
values,O
on,O
real,O
‐,O
time,O
PCR,O
for,O
the,O
N,O
gene,O
and,O
Orf1ab,O
gene,O
were,O
18.8,NUMBER
and,O
18.6,NUMBER
.,O
respectively,O
.,O
while,O
urine,O
and,O
stool,O
samples,O
remained,O
m,NUMBER
away,O
(,O
all,O
3,NUMBER
environment,O
sam,O
‐,O
ples,O
),O
were,O
found,O
to,O
be,O
positive,O
for,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
.,O
The,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
RdRp,O
28.7,NUMBER
.,O
33.3,NUMBER
.,O
and,O
29.7,NUMBER
.,O
respectively,O
.,O
For,O
all,O
3,NUMBER
samples,O
from,O
the,O
HCWs,O
.,O
PPE,O
were,O
found,O
to,O
be,O
negative,O
for,O
Demographics,O
:,O
Age,O
:,O
6,NUMBER
months,DURATION
.,O
Gender,O
:,O
NA,O
In,O
summary,O
.,O
a,O
generally,O
well,O
infant,O
with,O
COVID,O
‐,O
19,NUMBER
Clinical,O
characteristics,O
:,O
The,O
cycle,O
threshold,O
(,O
Ct,O
),O
val,O
‐,O
ues,O
can,O
contaminate,O
the,O
environment,O
with,O
PCR,O
‐,O
detectfor,O
N,O
gene,O
and,O
Orf1ab,O
gene,O
polymerase,O
chain,O
reaction,O
able,O
virus,O
.,O
Despite,O
close,O
physical,O
contact,O
with,O
the,O
(,O
PCR,O
),O
assay,O
were,O
15.6,NUMBER
and,O
13.7,NUMBER
.,O
respec,O
‐,O
tively,O
.,O
on,O
the,DATE
day,DATE
infant,O
during,O
feeding,O
.,O
the,O
evidence,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
on,O
the,O
gown,O
of,O
the,O
HCW,O
was,O
not,O
found,O
.,O
of,O
admission,O
.,O
Xu,PERSON
[,O
7,NUMBER
],O
.,O
China,COUNTRY
(,O
Guangzhou,CITY
.,O
Guangdong,STATE_OR_PROVINCE
Province,LOCATION
),O
.,O
Single,O
‐,O
center,O
Popula,LOCATION
‐,O
tion,O
setting,O
:,O
Between,O
22,DATE
January,DATE
2020,DATE
and,O
20,DATE
February,DATE
2020,DATE
.,O
745,NUMBER
highly,O
suspected,O
children,O
were,O
screened,O
by,O
real,O
‐,O
time,O
RTPCR,O
using,O
nasopharyngeal,O
swabs,O
to,O
detect,O
people,O
with,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
infection,CAUSE_OF_DEATH
.,O
10,NUMBER
children,O
tested,O
positive,O
and,O
were,O
admitted,O
to,O
Guangzhou,CITY
Women,O
and,O
Childrens,O
Medical,O
Centre,O
.,O
Ma,O
[,O
8,NUMBER
],O
.,O
China,COUNTRY
Province,LOCATION
),O
.,O
case,O
se,O
‐,O
ries,O
Population,O
setting,O
:,O
The,O
study,O
found,O
8,NUMBER
of,O
27,NUMBER
(,O
29.6,PERCENT
%,PERCENT
),O
Trans,O
‐,O
mission,O
route,O
:,O
All,O
6,NUMBER
children,O
had,O
close,O
conpatients,O
.,O
all,O
of,O
whom,O
were,O
diagnosed,O
with,O
mild,O
to,O
mod,O
‐,O
tact,O
with,O
infected,O
family,O
mem,O
‐,O
bers,O
.,O
erate,O
infection,CAUSE_OF_DEATH
and,O
discharged,O
12,DATE
weeks,DATE
ago,DATE
.,O
showed,O
posi,O
‐,O
tive,O
PCR,O
results,O
in,O
their,O
stool,O
but,O
negative,O
results,O
in,O
their,O
respiratory,O
specimens,O
.,O
Six,NUMBER
(,O
75,PERCENT
%,PERCENT
),O
of,O
these,O
8,NUMBER
patients,O
were,O
chil,O
‐,O
dren,O
.,O
Transmission,O
route,O
:,O
Four,NUMBER
of,O
them,O
had,O
definite,O
contact,O
his,O
‐,O
tory,O
with,O
a,O
confirmed,O
patient,O
.,O
seven,NUMBER
were,O
from,O
families,O
with,O
a,O
cluster,O
of,O
infection,CAUSE_OF_DEATH
and,O
7,NUMBER
had,O
travel,O
history,O
to,O
epidemic,O
areas,O
in,O
Hubei,STATE_OR_PROVINCE
Province,LOCATION
2,DURATION
weeks,DURATION
before,O
the,O
onset,O
of,O
infection,CAUSE_OF_DEATH
.,O
Demo,O
‐,O
graphics,O
:,O
Age,O
:,O
2,NUMBER
‐,O
188,DURATION
months,DURATION
(,O
mean,O
:,O
90.5,DURATION
months,DURATION
),O
.,O
Faecal,O
viral,O
shedding,O
:,O
Positive,O
real,O
‐,O
time,O
RTPCR,O
Gender,O
:,O
male,O
n,O
=,O
6,NUMBER
.,O
female,O
n,O
=,O
4,NUMBER
n,O
=,O
2,NUMBER
(,O
20,PERCENT
%,PERCENT
),O
;,O
diarrhoea,CAUSE_OF_DEATH
n,O
=,O
3,NUMBER
(,O
30,PERCENT
%,PERCENT
),O
;,O
more,O
than,O
one,NUMBER
sign,O
the,O
gas,O
‐,O
trointestinal,O
tract,O
may,O
shed,O
virus,O
and,O
faeco,O
oral,O
transmission,O
may,O
be,O
possible,O
.,O
Demographics,O
:,O
Age,O
:,O
11,NUMBER
‐,O
108,DURATION
months,DURATION
(,O
mean,O
:,O
55.8,NUMBER
Faecal,O
viral,O
shedding,O
:,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
can,O
be,O
shed,O
in,O
months,DURATION
),O
.,O
Gender,O
:,O
male,O
n,O
=,O
2,NUMBER
.,O
female,O
n,O
=,O
4,NUMBER
the,O
stool,O
of,O
patients,O
in,O
the,O
recovery,O
phase,O
.,O
Children,O
Clinical,O
characteristics,O
:,O
Presentation,O
:,O
fever,CAUSE_OF_DEATH
n,O
=,O
2,NUMBER
(,O
33.3,PERCENT
%,PERCENT
),O
show,O
a,O
longer,O
shedding,O
time,O
than,O
adults,O
.,O
Xing,PERSON
[,O
9,NUMBER
],O
.,O
China,COUNTRY
Province,LOCATION
),O
.,O
case,O
series,O
Population,O
setting,O
:,O
From,O
January,DATE
17,DATE
.,O
2020,DATE
to,O
February,DATE
23,DATE
.,DATE
2020,DATE
.,O
three,NUMBER
paediatric,O
cases,O
of,O
COVID,O
‐,O
19,NUMBER
were,O
reported,O
in,O
Qingdao,CITY
.,O
Shandong,STATE_OR_PROVINCE
Province,LOCATION
.,O
China,COUNTRY
.,O
Epidemiologi,O
‐,O
cal,O
.,O
clinical,O
.,O
laboratory,O
.,O
and,O
radiological,O
characteristics,O
and,O
treatment,O
data,O
were,O
collected,O
.,O
Patients,O
were,O
followed,O
up,O
to,O
March,DATE
10,NUMBER
.,O
2020,DATE
.,O
and,O
dynamic,O
profiles,O
of,O
nucleic,O
acid,O
testing,O
results,O
in,O
throat,O
swabs,O
and,O
faecal,O
specimens,O
were,O
closely,O
monitored,O
.,O
Trans,MISC
‐,O
mission,O
route,O
:,O
None,O
of,O
these,O
children,O
had,O
travel,O
history,O
outside,O
of,O
Qingdao,CITY
one,DURATION
month,DURATION
before,O
onset,O
of,O
the,O
disease,CAUSE_OF_DEATH
.,O
All,O
three,NUMBER
chil,O
‐,O
dren,O
were,O
infected,O
because,O
of,O
close,O
contact,O
with,O
infected,O
family,O
members,O
.,O
There,O
was,O
no,O
evidence,O
showing,O
the,O
virus,O
was,O
transmitted,O
from,O
the,O
children,O
to,O
others,O
.,O
Demographics,O
:,O
Case,O
1,NUMBER
:,O
age,O
:,O
1.5,NUMBER
years,DURATION
;,O
gender,O
:,O
male,O
.,O
Case,O
Faecal,O
viral,O
shedding,O
:,O
Case,O
1,NUMBER
and,O
2,NUMBER
:,O
RT,O
‐,O
PCR,O
re2,O
:,O
age,O
:,O
5,DURATION
years,DURATION
;,O
gender,O
:,O
male,O
.,O
Case,O
3,NUMBER
:,O
age,O
:,O
6,DURATION
years,DURATION
;,O
gen,O
‐,O
der,O
:,O
sults,O
remained,O
positive,O
in,O
stools,O
of,O
the,O
two,NUMBER
children,O
for,O
8,NUMBER
and,O
20,NUMBER
d,O
.,O
respectively,O
.,O
after,O
nucleic,O
acid,O
turnClinical,O
charac,O
‐,O
teristics,O
:,O
Presentation,O
:,O
fever,CAUSE_OF_DEATH
n,O
=,O
3,NUMBER
(,O
100,PERCENT
%,PERCENT
),O
;,O
ing,O
negative,O
in,O
res,O
‐,O
piratory,O
samples,O
.,O
Case,O
3,NUMBER
:,O
Clearcough,O
n,O
=,O
1,NUMBER
(,O
33.3,PERCENT
%,PERCENT
),O
;,O
stuffy,O
nose,O
n,O
=,O
1,NUMBER
(,O
33.3,PERCENT
%,PERCENT
),O
;,O
abdominal,O
ance,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
in,O
stool,O
samples,O
oc,O
‐,O
curred,O
20,DURATION
days,DURATION
after,O
viral,O
RNA,MISC
in,O
respiratory,O
specimens,O
turnpain,O
n,O
=,O
1,NUMBER
(,O
33.3,PERCENT
%,PERCENT
),O
;,O
diarrhea,O
n,O
=,O
1,NUMBER
(,O
33.3,PERCENT
%,PERCENT
),O
ing,O
negative,O
.,O
June,DATE
2020,DATE
Vol.,O
10,NUMBER
No.,O
1,NUMBER
011101,NUMBER
Terry,PERSON
[,O
10,NUMBER
],O
.,O
Germany,COUNTRY
(,O
Berlin,CITY
),O
.,O
Retrospective,O
study,O
Population,O
setting,O
:,O
From,O
January,DATE
to,O
26,DATE
April,DATE
2020,DATE
.,O
virology,O
laboratories,O
at,O
Charite,ORGANIZATION
and,O
Labor,LOCATION
Berlin,CITY
screened,O
59,NUMBER
831,NUMBER
patients,O
for,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
.,O
3712,NUMBER
(,O
6.2,PERCENT
%,PERCENT
),O
with,O
a,O
positive,O
real,O
‐,O
time,O
RT,O
‐,O
PCR,O
result,O
.,O
Patients,O
were,O
divided,O
according,O
to,O
two,NUMBER
categoriza,O
‐,O
tions,O
to,O
investigate,O
whether,O
there,O
is,O
a,O
relationship,O
between,O
pa,O
‐,O
tient,O
age,O
and,O
viral,O
load,O
.,O
The,O
first,ORDINAL
categorization,O
is,O
based,O
on,O
ten,NUMBER
‐,O
year,DURATION
brackets,O
.,O
The,O
second,ORDINAL
categorization,O
is,O
based,O
on,O
broad,O
adult,O
(,O
26,NUMBER
‐,O
45,NUMBER
),O
.,O
and,O
mature,O
(,O
age,O
over,O
45,NUMBER
),O
.,O
Demographics,O
:,O
Kinder,O
‐,O
garten,O
(,O
ages,O
0,NUMBER
‐,O
6,NUMBER
),O
:,O
n,O
=,O
1759,DATE
),O
;,O
(,O
ages,O
26,NUMBER
‐,O
45,NUMBER
),O
:,O
n,O
=,O
23,NUMBER
665,NUMBER
;,O
Mature,O
(,O
age,O
over,O
45,NUMBER
),O
:,O
n,O
=,O
27,NUMBER
407,NUMBER
Clinical,O
characteristics,O
:,O
Positive,O
PCR,O
counts,O
and,O
percentages,O
.,O
Kindergarten,O
(,O
ages,O
0,NUMBER
‐,O
6,NUMBER
),O
:,O
n,O
=,O
37,NUMBER
(,O
2.10,PERCENT
%,PERCENT
),O
;,O
Grade,O
(,O
5.82,PERCENT
%,PERCENT
),O
;,O
Adult,O
(,O
ages,O
26,NUMBER
‐,O
45,NUMBER
),O
:,O
n,O
=,O
1247,DATE
(,O
5.27,PERCENT
%,PERCENT
),O
;,O
Mature,O
(,O
age,O
over,O
45,NUMBER
),O
:,O
n,O
=,O
2071,DATE
(,O
7.56,PERCENT
%,PERCENT
),O
Population,O
setting,O
:,O
Nationwide,O
case,O
series,O
of,O
2135,DATE
paeDong,O
[,O
3,NUMBER
],O
.,O
China,COUNTRY
(,O
nationwide,O
),O
.,O
Retro,O
‐,O
diatric,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
reported,O
to,O
the,O
Chinese,NATIONALITY
were,O
728,NUMBER
(,O
34.1,PERCENT
%,PERCENT
),O
laboratory,O
‐,O
confirmed,O
cases,O
and,O
1407,DATE
(,O
65.9,PERCENT
%,PERCENT
),O
suspected,O
cases,O
.,O
De,O
‐,O
mographics,O
:,O
Age,O
:,O
1,NUMBER
day18,O
years,DURATION
(,O
mean,O
:,O
7,DURATION
years,DURATION
),O
;,O
Gender,O
:,O
male,O
n,O
=,O
1208,DATE
(,O
56.6,PERCENT
%,PERCENT
),O
.,O
female,O
n,O
=,O
927,NUMBER
(,O
43.4,PERCENT
%,PERCENT
),O
Clinical,O
characteristics,O
:,O
Regarding,O
the,O
severity,O
(,O
including,O
both,O
confirmed,O
and,O
suspected,O
cases,O
),O
.,O
94,NUMBER
(,O
4.4,PERCENT
%,PERCENT
),O
.,O
1088,DATE
(,O
51.0,PERCENT
%,PERCENT
),O
.,O
and,O
826,NUMBER
(,O
38.7,PERCENT
%,PERCENT
),O
cases,O
were,O
diag,O
‐,O
nosed,O
as,O
asymptomatic,O
.,O
mild,O
.,O
or,O
moderate,O
.,O
respectively,O
;,O
account,O
‐,O
ing,O
for,O
94.1,PERCENT
%,PERCENT
of,O
all,O
cases,O
.,O
However,O
.,O
the,O
proportion,O
of,O
severe,O
and,O
critical,O
cases,O
was,O
10.6,PERCENT
%,PERCENT
.,O
7.3,PERCENT
%,PERCENT
.,O
4.2,PERCENT
%,PERCENT
.,O
4.1,PERCENT
%,PERCENT
.,O
and,O
3.0,PERCENT
%,PERCENT
for,O
the,O
age,O
groups,O
.,O
1,NUMBER
.,O
1,NUMBER
to,O
5,NUMBER
.,O
6,NUMBER
to,O
10,NUMBER
.,O
11,NUMBER
to,O
15,NUMBER
.,O
and,O
over,O
15,DURATION
years,DURATION
.,O
respec,O
‐,O
tively,O
.,O
These,O
results,O
suggest,O
that,O
young,O
children,O
.,O
particularly,O
infants,O
.,O
were,O
vulnerable,O
to,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
infection,CAUSE_OF_DEATH
.,O
Viral,O
load,O
distribution,O
:,O
Kindergarten,O
(,O
ages,O
0,NUMBER
‐,O
6,NUMBER
),O
:,O
Adult,O
(,O
ages,O
26,NUMBER
‐,O
4,NUMBER
5,NUMBER
),O
:,O
n,O
=,O
1247,DATE
(,O
mean,O
:,O
5.23,NUMBER
;,O
SD,STATE_OR_PROVINCE
:,O
1.87,NUMBER
),O
;,O
Mature,O
(,O
age,O
over,O
45,NUMBER
),O
:,O
n,O
=,O
2071,DATE
(,O
mean,O
:,O
5.28,NUMBER
;,O
SD,STATE_OR_PROVINCE
:,O
1.95,NUMBER
),O
.,O
The,O
study,O
found,O
no,O
significant,O
differences,O
in,O
viral,O
load,O
exists,O
between,O
different,O
age,O
subgroups,O
.,O
However,O
.,O
there,O
were,O
smaller,O
sample,O
sizes,O
in,O
the,O
paediatric,O
age,O
groups,O
.,O
Transmission,O
route,O
:,O
Approximately,O
half,O
of,O
the,O
patients,O
were,O
from,O
Hubei,STATE_OR_PROVINCE
province,O
(,O
981,NUMBER
;,O
46.0,PERCENT
%,PERCENT
),O
.,O
whereas,O
396,NUMBER
(,O
18.5,PERCENT
%,PERCENT
),O
case,O
patients,O
were,O
from,O
Anhui,STATE_OR_PROVINCE
.,O
Henan,STATE_OR_PROVINCE
.,O
Hunan,STATE_OR_PROVINCE
.,O
Jiangxi,STATE_OR_PROVINCE
.,O
Shanxi,STATE_OR_PROVINCE
and,O
Chongqing,CITY
.,O
which,O
border,O
Hubei,STATE_OR_PROVINCE
province,LOCATION
.,O
In,O
the,O
spatial,O
distribution,O
.,O
there,O
was,O
a,O
clear,O
trend,O
that,O
disease,CAUSE_OF_DEATH
spread,O
rapidly,O
from,O
Hubei,STATE_OR_PROVINCE
province,LOCATION
to,O
surrounding,O
provinces,O
and,O
cities,O
over,O
time,O
.,O
There,O
were,O
more,O
children,O
infected,O
in,O
the,O
areas,O
around,O
Hubei,STATE_OR_PROVINCE
province,O
than,O
in,O
ar,O
‐,O
eas,O
farther,O
away,O
except,O
for,O
Heilongjiang,LOCATION
province,LOCATION
.,O
This,O
study,O
provided,O
strong,O
evidence,O
at,O
the,O
start,O
of,O
the,O
outbreak,O
of,O
human,O
‐,O
to,O
‐,O
human,O
At,O
least,O
three,NUMBER
studies,O
have,O
shown,O
that,O
children,O
show,O
prolonged,O
faecal,O
shedding,O
compared,O
to,O
adults,O
(,O
and,O
well,O
after,O
na,O
‐,O
sopharyngeal,O
swabs,O
turned,O
negative,O
.,O
The,O
researchers,O
of,O
one,NUMBER
study,O
also,O
found,O
that,O
the,O
viral,O
load,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
in,O
the,O
gastroin,O
‐,O
testinal,O
tract,O
was,O
greater,O
and,O
lasted,O
longer,O
than,O
that,O
in,O
the,O
respiratory,O
system,O
[,O
9,NUMBER
],O
.,O
These,O
findings,O
lead,O
to,O
concerns,O
about,O
the,O
potential,O
for,O
faeco,O
‐,O
oral,O
transmission,O
of,O
SARSCoV,O
‐,O
2,NUMBER
.,O
particularly,O
in,O
infants,O
and,O
children,O
who,O
are,O
not,O
toilet,O
‐,O
trained,O
and,O
who,O
have,O
poorer,O
hand,O
hygiene,O
.,O
A,O
study,O
of,O
3712,NUMBER
COVID,O
‐,O
19,NUMBER
patients,O
analysed,O
the,O
variance,O
of,O
viral,O
loads,O
in,O
patients,O
of,O
different,O
age,O
cate,O
‐,O
gories,O
[,O
10,NUMBER
],O
.,O
They,O
initially,O
reported,O
a,O
similar,O
viral,O
load,O
in,O
children,O
as,O
in,O
adults,O
[,O
10,NUMBER
],O
.,O
however,O
.,O
re,O
‐,O
analysis,O
of,O
these,O
data,O
show,O
that,O
young,O
children,O
(,O
<,O
10,DURATION
years,DURATION
old,DURATION
),O
had,O
statistically,O
sig,O
‐,O
nificant,O
lower,O
viral,O
load,O
[,O
19,NUMBER
],O
.,O
It,O
is,O
estimated,O
that,O
the,O
propor,O
‐,O
tion,O
of,O
infected,O
children,O
with,O
latent,O
asymptomatic,O
or,O
with,O
mild,O
symptoms,O
of,O
respiratory,O
illness,CAUSE_OF_DEATH
is,O
higher,O
than,O
in,O
adults,O
.,O
which,O
highlights,O
the,O
possibility,O
that,O
children,O
and,O
young,O
adolescents,O
may,O
be,O
potential,O
sources,O
of,O
undetected,O
community,O
transmission,O
[,O
3,NUMBER
],O
.,O
A,O
nationwide,O
case,O
‐,O
series,O
of,O
2135,DATE
paediatric,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
reported,O
to,O
the,O
Chinese,NATIONALITY
Centre,O
for,O
Disease,CAUSE_OF_DEATH
Control,O
and,O
Prevention,O
found,O
that,O
more,O
than,O
90,PERCENT
%,PERCENT
had,O
asymptomatic,O
(,O
4,PERCENT
%,PERCENT
),O
.,O
mild,O
(,O
50.9,PERCENT
%,PERCENT
),O
.,O
or,O
moderate,O
(,O
38.8,PERCENT
%,PERCENT
),O
symptoms,O
[,O
3,NUMBER
],O
.,O
This,O
is,O
a,O
hospital,O
‐,O
based,O
study,O
.,O
which,O
may,O
underestimate,O
the,O
true,O
rate,O
of,O
asympto,O
‐,O
matic,O
infection,CAUSE_OF_DEATH
.,O
since,O
many,O
asymptomatic,O
children,O
are,O
unlikely,O
to,O
be,O
hospitalised,O
or,O
tested,O
[,O
3,NUMBER
],O
.,O
While,O
there,O
are,O
studies,O
describing,O
the,O
infective,O
potential,O
of,O
asymptomatic,O
adult,O
cases,O
[,O
20.21,NUMBER
],O
.,O
few,O
describe,O
this,O
in,O
children,O
.,O
June,DATE
2020,DATE
Vol.,O
10,NUMBER
No.,O
1,NUMBER
011101,NUMBER
RE,O
‐,O
SEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
OF,O
COVID,O
‐,O
19,NUMBER
EVIDENCE,O
Children,O
and,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
OF,O
COVID,O
‐,O
19,NUMBER
EVIDENCE,O
RESEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
Li,PERSON
et,O
al,O
.,O
an,O
outbreak,O
of,O
COVID,O
‐,O
19,NUMBER
[,O
5,NUMBER
],O
.,O
They,O
found,O
that,O
40.9,PERCENT
%,PERCENT
of,O
pupils,O
and,O
staff,O
(,O
with,O
no,O
significant,O
difference,O
and,O
siblings,O
of,O
infected,O
pupils,O
were,O
also,O
infected,O
.,O
However,O
.,O
it,O
should,O
be,O
noted,O
that,O
almost,O
all,O
the,O
students,O
in,O
the,O
study,O
were,O
aged,O
15,NUMBER
‐,O
17,DURATION
years,DURATION
of,O
age,O
.,O
and,O
appeared,O
to,O
have,O
similar,O
disease,CAUSE_OF_DEATH
characteristics,O
to,O
young,O
adults,O
.,O
Therefore,O
.,O
the,O
rate,O
of,O
infection,CAUSE_OF_DEATH
reported,O
might,O
be,O
not,O
applicable,O
to,O
younger,O
children,O
.,O
One,NUMBER
case,O
report,O
describes,O
a,O
paediatric,O
patient,O
who,O
was,O
infected,O
during,O
a,O
holiday,O
in,O
France,COUNTRY
[,O
12,NUMBER
],O
.,O
Despite,O
a,O
large,O
number,O
of,O
contacts,O
in,O
different,O
classes,O
after,O
returning,O
to,O
the,O
UK,COUNTRY
.,O
the,O
paediatric,O
case,O
did,O
not,O
transmit,O
the,O
disease,CAUSE_OF_DEATH
to,O
any,O
other,O
pupils,O
.,O
Proportion,O
of,O
children,O
infected,O
by,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
We,O
next,O
sought,O
to,O
identify,O
stud,O
‐,O
ies,O
which,O
estimated,O
the,O
proportion,O
of,O
children,O
infected,O
in,O
the,O
community,O
.,O
We,O
included,O
five,NUMBER
studies,O
[,O
13,NUMBER
‐,O
17,NUMBER
],O
estimating,O
the,O
pro,O
‐,O
portion,O
of,O
children,O
infected,O
through,O
either,O
random,O
or,O
Targeted,O
(,O
n,O
=,O
9199,NUMBER
),O
and,O
random,O
population,O
screening,O
(,O
n,O
=,O
13,NUMBER
607,NUMBER
),O
from,O
Iceland,COUNTRY
found,O
that,O
children,O
under,O
10,NUMBER
were,O
less,O
likely,O
to,O
test,O
positive,O
than,O
those,O
10,NUMBER
and,O
over,O
(,O
6.7,PERCENT
%,PERCENT
vs,O
13.7,PERCENT
%,PERCENT
for,O
targeted,O
testing,O
;,O
and,O
0,PERCENT
%,PERCENT
vs,O
National,ORGANIZATION
Centre,ORGANIZATION
for,ORGANIZATION
Immunisation,ORGANIZATION
Research,ORGANIZATION
and,ORGANIZATION
Surveillance,ORGANIZATION
(,O
NCIRS,O
),O
[,O
5,NUMBER
],O
.,O
Australia,COUNTRY
(,O
New,LOCATION
South,LOCATION
Wales,LOCATION
),O
.,O
were,O
confirmed,O
as,O
COVID,O
‐,O
19,NUMBER
cases,O
;,O
735,NUMBER
students,O
and,O
128,NUMBER
staff,O
were,O
close,O
contacts,O
of,O
these,O
initial,O
cases,O
.,O
Arnaud,PERSON
[,O
11,NUMBER
],O
.,O
French,NATIONALITY
Population,MISC
setting,O
:,O
661,NUMBER
participants,O
included,O
pupils,O
.,O
their,O
parents,O
and,O
siblings,O
.,O
as,O
well,O
as,O
teachers,O
and,O
non,O
‐,O
teaching,O
staff,O
Demographics,O
:,O
Age,O
:,O
14,DURATION
years,DURATION
(,O
n,O
=,O
37,NUMBER
),O
;,O
15,NUMBER
‐,O
17,DURATION
years,DURATION
(,O
n,O
=,O
205,NUMBER
),O
Case,O
confirmation,O
:,O
A,O
participant,O
with,O
positive,O
serology,O
at,O
the,O
time,DATE
of,O
blood,O
sampling,O
was,O
consid,O
‐,O
ered,O
as,O
a,O
confirmed,O
case,O
.,O
Population,O
setting,O
:,O
A,O
paediatric,O
pa,O
‐,O
tient,O
was,O
confirmed,O
as,O
a,O
secondary,O
case,O
by,O
close,O
contacts,O
with,O
the,O
index,O
case,O
in,O
Demographics,O
:,O
9,DURATION
year,DURATION
‐,O
old,O
child,O
with,O
respiratory,O
symptoms,O
DANIS,PERSON
[,O
12,NUMBER
],O
.,O
French,NATIONALITY
(,O
Alps,O
),O
.,O
a,O
Confirmed,O
transmission,O
:,O
Transmission,O
from,O
infected,O
students,O
/,O
staff,O
to,O
students,O
:,O
n,O
=,O
2,NUMBER
;,O
No,O
confirmed,O
transmission,O
from,O
students,O
to,O
staff,O
;,O
One,NUMBER
secondary,O
a,O
staff,O
member,O
(,O
teacher,TITLE
),O
who,O
was,O
a,O
case,O
.,O
Demographics,O
:,O
Not,O
report,O
‐,O
ed,O
Mean,O
time,O
to,O
transmission,O
/,O
symptoms,O
onset,O
:,O
One,NUMBER
Case,O
confirma,O
‐,O
tion,O
:,O
Participants,O
were,O
swabbed,O
for,O
SARS,O
‐,O
of,O
them,O
was,O
diagnosed,O
by,O
nose,O
/,O
throat,O
swab,O
testing,O
CoV,O
‐,O
2,NUMBER
virus,O
testing,O
and,O
had,O
a,O
blood,O
sample,O
taken,O
to,O
detect,O
5,NUMBER
‐,O
10,DURATION
days,DURATION
after,O
the,O
last,O
contact,O
and,O
one,NUMBER
had,O
a,O
positive,O
antibody,O
test,O
4,DURATION
weeks,DURATION
after,O
their,O
exposure,O
.,O
anti,O
‐,O
bodies,O
to,O
the,O
virus,O
.,O
June,DATE
2020,DATE
Vol.,O
10,NUMBER
No.,O
1,NUMBER
011101,NUMBER
Confirmed,O
transmission,O
:,O
92,NUMBER
out,O
of,O
240,NUMBER
pupils,O
had,O
anti,O
‐,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
antibod,O
‐,O
ies,O
.,O
and,O
the,O
infection,CAUSE_OF_DEATH
attack,CAUSE_OF_DEATH
rate,O
(,O
IAR,ORGANIZATION
),O
was,O
38.3,PERCENT
%,PERCENT
among,O
chil,O
‐,O
dren,O
.,O
The,O
overall,O
infection,CAUSE_OF_DEATH
attack,CAUSE_OF_DEATH
rate,O
(,O
IAR,ORGANIZATION
),O
was,O
40.9,PERCENT
%,PERCENT
in,O
the,O
high,O
while,O
symptomatic,O
.,O
but,O
did,O
not,O
transmit,O
the,O
virus,O
.,O
Gudb,O
‐,O
jartsson,O
[,O
13,NUMBER
],O
.,O
Iceland,COUNTRY
.,O
Population,O
setting,O
:,O
9919,DATE
persons,O
(,O
564,NUMBER
children,O
),O
from,O
the,O
high,O
‐,O
risk,O
population,O
(,O
mainly,O
those,O
who,O
were,O
symptomatic,O
.,O
had,O
recently,DATE
travelled,O
to,O
high,O
‐,O
risk,O
countries,O
.,O
or,O
had,O
contact,O
with,O
infected,O
persons,O
),O
.,O
and,O
13080,NUMBER
persons,O
(,O
848,NUMBER
chil,O
‐,O
dren,O
),O
from,O
the,O
population,O
‐,O
screening,O
programme,O
Demographics,O
:,O
Age,O
:,O
<,O
10,DURATION
years,DURATION
Proportion,O
of,O
children,O
infected,O
by,O
COVID,O
‐,O
19,NUMBER
:,O
38,NUMBER
(,O
6.7,PERCENT
%,PERCENT
),O
children,O
from,O
the,O
high,O
‐,O
risk,O
group,O
tested,O
positive,O
.,O
in,O
contrast,O
to,O
1183,DATE
of,O
8635,NUMBER
persons,O
(,O
13.7,PERCENT
%,PERCENT
),O
who,O
were,O
10,DURATION
years,DURATION
of,O
age,O
or,O
older,O
.,O
In,O
the,O
population,O
‐,O
screening,O
group,O
.,O
none,O
of,O
the,O
848,NUMBER
children,O
test,O
‐,O
ed,O
positive,O
Case,O
confirmation,O
:,O
RNA,O
sequencing,O
Population,O
setting,O
:,O
5155,NUMBER
persons,O
(,O
234,NUMBER
children,O
),O
from,O
2,NUMBER
pop,O
‐,O
Proportion,O
of,O
children,O
infected,O
by,O
COVID,O
‐,O
19,NUMBER
:,O
ulation,O
‐,O
based,O
surveys,O
None,O
of,O
the,O
234,NUMBER
chil,O
‐,O
dren,O
tested,O
positive,O
.,O
COVID,O
‐,O
19,NUMBER
National,O
Emergency,O
Response,O
Cen,O
‐,O
tre,O
Population,O
setting,O
:,O
7755,NUMBER
cases,O
(,O
480,NUMBER
children,O
),O
from,O
2,NUMBER
popu,O
‐,O
Proportion,O
of,O
children,O
infected,O
by,O
COVID,O
‐,O
19,NUMBER
:,O
lation,O
‐,O
based,O
surveys,O
1,PERCENT
%,PERCENT
of,O
confirmed,O
cases,O
were,O
<,O
10,DURATION
years,DURATION
old,DURATION
and,O
Demographics,O
:,O
Age,O
:,O
0,NUMBER
‐,O
9,DURATION
years,DURATION
(,O
n,O
=,O
75,NUMBER
),O
;,O
10,NUMBER
‐,O
19,DURATION
years,DURATION
(,O
n,O
=,O
405,NUMBER
),O
5.2,PERCENT
%,PERCENT
were,O
10,NUMBER
‐,O
19,DURATION
years,DURATION
old,O
.,O
Health,O
and,O
Environment,O
.,O
Children,O
and,O
COVID,O
‐,O
19,NUMBER
(,O
PIENTER,O
Corona,O
study,O
),O
[,O
16,NUMBER
],O
.,O
Netherlands,COUNTRY
.,O
population,O
‐,O
based,O
survey,O
Popula,O
‐,O
tion,O
setting,O
:,O
6100,NUMBER
persons,O
(,O
480,NUMBER
children,O
),O
from,O
the,O
PI,O
‐,O
Proportion,O
of,O
children,O
infected,O
by,O
COVID,O
‐,O
19,NUMBER
:,O
ENTER,O
Corona,O
study,O
2,PERCENT
%,PERCENT
tested,O
positive,O
for,O
antibodies,O
in,O
their,O
blood,O
.,O
Population,O
setting,O
:,O
3330,DATE
persons,O
(,O
889,NUMBER
children,O
),O
recruited,O
Proportion,O
of,O
children,O
infected,O
by,O
COVID,O
‐,O
19,NUMBER
:,O
from,O
residents,O
in,O
Santa,CITY
Clara,CITY
county,O
Among,O
621,NUMBER
chil,O
‐,O
dren,O
who,O
were,O
tested,O
.,O
1.4,PERCENT
%,PERCENT
of,O
children,O
0,NUMBER
‐,O
4,DURATION
years,DURATION
old,DURATION
and,O
1.5,PERCENT
%,PERCENT
of,O
children,O
5,NUMBER
‐,O
18,NUMBER
Demographics,O
:,O
Age,O
:,O
<,O
19,DURATION
years,DURATION
years,DURATION
old,O
tested,O
posi,O
‐,O
tive,O
.,O
Case,O
confirmation,O
:,O
Blood,O
antibodies,O
Annemarie,PERSON
[,O
18,NUMBER
],O
.,O
UK,COUNTRY
(,O
166,NUMBER
Population,O
setting,O
:,O
16,NUMBER
749,NUMBER
people,O
with,O
COVID,O
‐,O
19,NUMBER
diagnosed,O
Proportion,O
of,O
children,O
infected,O
by,O
COVID,O
‐,O
19,NUMBER
:,O
from,O
166,NUMBER
UK,COUNTRY
hospi,O
‐,O
tals,O
between,O
6,DATE
February,DATE
and,DATE
18,DATE
April,DATE
2020,DATE
.,O
Severe,O
COVID,O
‐,O
19,NUMBER
infec,O
‐,O
tions,O
are,O
rare,O
in,O
those,O
unDemographics,O
:,O
The,O
median,O
age,O
was,O
72,NUMBER
years,DURATION
(,O
IQR,O
57,NUMBER
.,O
82,NUMBER
;,O
der,O
18,DURATION
years,DURATION
of,O
age,O
.,O
comprising,O
1.4,PERCENT
%,PERCENT
of,O
those,O
adrange,O
0,NUMBER
.,O
104,NUMBER
),O
.,O
the,O
median,O
duration,O
of,O
symptoms,O
before,O
admis,O
‐,O
mitted,O
to,O
hospital,O
.,O
Only,O
0.8,PERCENT
%,PERCENT
of,O
those,O
in,O
the,O
study,O
sion,O
was,O
4,NUMBER
days,DURATION
(,O
IQR,O
1,NUMBER
.,O
8,NUMBER
),O
and,O
the,O
median,O
duration,O
of,O
hospital,O
were,O
under,O
5,NUMBER
years,DURATION
of,O
age,O
.,O
Demographics,O
:,O
Age,O
:,O
<,O
10,DURATION
years,DURATION
Case,O
confirmation,O
:,O
Real,O
time,O
RT,O
‐,O
PCR,O
Case,O
confirmation,O
:,O
Laboratory,O
‐,O
confirmed,O
cases,O
Demographics,O
:,O
Age,O
:,O
<,O
20,DURATION
years,DURATION
Case,O
confirmation,O
:,O
Blood,O
antibodies,O
stay,O
was,O
7,DURATION
days,DURATION
(,O
IQR,O
4,NUMBER
.,O
12,NUMBER
),O
.,O
0.8,PERCENT
%,PERCENT
for,O
random,O
population,O
testing,O
),O
[,O
13,NUMBER
],O
.,O
The,O
Italian,NATIONALITY
principality,O
of,O
Vo,O
tested,O
>,O
85,PERCENT
%,PERCENT
of,O
their,O
popula,O
‐,O
tion,O
following,O
their,O
first,ORDINAL
death,O
from,O
COVID,O
‐,O
19,NUMBER
and,O
found,O
no,O
posi,O
‐,O
tive,O
cases,O
in,O
children,O
despite,O
2.6,PERCENT
%,PERCENT
of,O
the,O
population,O
testing,O
positive,O
[,O
14,NUMBER
],O
.,O
A,O
demographic,O
breakdown,O
of,O
the,O
first,ORDINAL
7755,NUMBER
labora,O
‐,O
tory,O
‐,O
confirmed,O
cases,O
in,O
South,COUNTRY
Korea,COUNTRY
(,O
where,O
extensive,O
community,O
testing,O
has,O
been,O
implemented,O
),O
showed,O
that,O
only,O
1,PERCENT
%,PERCENT
of,O
the,O
con,O
‐,O
firmed,O
cases,O
were,O
<,O
10,DURATION
years,DURATION
old,DURATION
and,O
5.2,PERCENT
%,PERCENT
were,O
10,NUMBER
‐,O
19,DURATION
years,DURATION
old,DURATION
[,O
15,NUMBER
],O
.,O
A,O
study,O
in,O
the,O
Netherlands,COUNTRY
is,O
undertaking,O
community,O
serolo,O
‐,O
gy,O
testing,O
for,O
antibodies,O
against,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
and,O
in,O
their,O
first,ORDINAL
release,O
of,O
preliminary,O
results,O
they,O
have,O
found,O
4.2,PERCENT
%,PERCENT
of,O
adults,O
were,O
positive,O
compared,O
to,O
2,PERCENT
%,PERCENT
of,O
those,O
aged,O
<,O
20,DURATION
years,DURATION
[,O
16,NUMBER
],O
.,O
Final,O
‐,O
ly,O
.,O
a,O
COVID,O
‐,O
19,NUMBER
antibody,O
seroprevalence,O
study,O
in,O
Santa,O
Clara,O
Coun,O
‐,O
ty,O
.,O
California,STATE_OR_PROVINCE
showed,O
that,O
positivity,O
of,O
the,O
antibody,O
test,O
was,O
not,O
significantly,O
different,O
across,O
age,O
groups,O
(,O
but,O
children,O
were,O
from,O
the,O
same,O
households,O
of,O
the,O
adults,O
that,O
were,O
selected,O
for,O
testing,O
),O
[,O
18,NUMBER
],O
.,O
There,O
is,O
no,O
population,O
‐,O
based,O
study,O
in,O
the,O
UK,COUNTRY
to,O
accurately,O
assess,O
the,O
level,O
of,O
infection,CAUSE_OF_DEATH
in,O
the,O
community,O
.,O
An,O
IS,O
‐,O
ARIC,ORGANIZATION
study,O
of,O
16,NUMBER
749,NUMBER
hospitalised,O
UK,COUNTRY
patients,O
with,O
COVID,O
‐,O
19,NUMBER
from,O
166,NUMBER
UK,COUNTRY
hospitals,O
found,O
that,O
only,O
2,PERCENT
%,PERCENT
of,O
the,O
patients,O
were,O
under,O
18,NUMBER
years,DURATION
old,O
(,O
n,O
=,O
239,NUMBER
patients,O
),O
and,O
1.1,PERCENT
%,PERCENT
were,O
under,O
5,DURATION
years,DURATION
old,DURATION
(,O
n,O
=,O
139,NUMBER
patients,O
),O
[,O
18,NUMBER
],O
.,O
that,O
transmission,O
by,O
children,O
is,O
possible,O
but,O
do,O
not,O
quantify,O
the,O
likelihood,O
of,O
transmission,O
in,O
children,O
compared,O
to,O
adults,O
.,O
(,O
ii,O
),O
There,O
is,O
theoretical,O
evidence,O
that,O
al,O
‐,O
ternative,O
transmission,O
routes,O
such,O
as,O
faeco,O
‐,O
oral,O
June,DATE
2020,DATE
Vol,O
.,O
10,NUMBER
No.,O
1,NUMBER
011101,NUMBER
RESEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
OF,O
COVID,O
‐,O
19,NUMBER
EVI,O
‐,O
DENCE,MISC
Children,MISC
and,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
OF,O
COVID,O
‐,O
19,NUMBER
EVI,O
‐,O
DENCE,O
RESEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
Li,O
et,O
al,O
.,O
transmission,O
may,O
pose,O
a,O
higher,O
risk,O
in,O
children,O
.,O
Further,O
investigation,O
is,O
required,O
to,O
confirm,O
whether,O
have,O
remained,O
open,O
.,O
(,O
iv,O
),O
Children,O
are,O
infect,O
‐,O
ed,O
.,O
but,O
perhaps,O
less,O
frequently,O
than,O
adults,O
.,O
However,O
.,O
these,O
stud,O
‐,O
ies,O
are,O
limited,O
by,O
small,O
numbers,O
and,O
additional,O
community,O
sero,O
‐,O
prevalence,O
surveys,O
are,O
needed,O
to,O
confirm,O
the,O
proportion,O
of,O
chil,O
‐,O
dren,O
infected,O
.,O
Direct,O
evidence,O
showing,O
children,O
as,O
a,O
source,O
of,O
transmission,O
is,O
scarce,O
and,O
largely,O
based,O
on,O
small,O
studies,O
or,O
studies,O
investigating,O
few,O
paediatric,O
cases,O
.,O
We,O
identified,O
two,NUMBER
studies,O
indicating,O
that,O
children,O
can,O
transmit,O
COVID,O
‐,O
19,NUMBER
to,O
other,O
children,O
or,O
adults,O
[,O
4.5,NUMBER
],O
.,O
however,O
.,O
these,O
studies,O
have,O
a,O
high,O
de,O
‐,O
gree,O
of,O
uncertainty,O
.,O
The,O
early,O
case,O
series,O
of,O
paediatric,O
cases,O
in,O
China,COUNTRY
[,O
4,NUMBER
],O
(,O
providing,O
evidence,O
on,O
children,O
as,O
a,O
source,O
of,O
adult,O
infection,CAUSE_OF_DEATH
),O
has,O
been,O
questioned,O
by,O
the,O
Swiss,NATIONALITY
National,O
Science,O
Task,O
Force,O
group,O
[,O
22,NUMBER
],O
.,O
who,O
stated,O
that,O
a,O
check,O
of,O
the,O
original,O
data,O
does,O
not,O
confirm,O
the,O
reported,O
transmission,O
from,O
the,O
infant,O
to,O
their,O
parents,O
.,O
transmission,O
chains,O
in,O
such,O
a,O
widespread,O
outbreak,O
[,O
5,NUMBER
],O
.,O
While,O
there,O
is,O
lack,O
of,O
direct,O
evidence,O
on,O
the,O
frequency,O
that,O
children,O
transmit,O
the,O
disease,CAUSE_OF_DEATH
.,O
indirect,O
evidence,O
illustrates,O
the,O
potential,O
risk,O
of,O
viral,O
transmission,O
by,O
children,O
.,O
First,ORDINAL
.,O
there,O
is,O
evidence,O
showing,O
that,O
an,O
infected,O
infant,O
contaminated,O
(,O
with,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
),O
the,O
surfaces,O
they,O
were,O
in,O
contact,O
with,O
.,O
thus,O
rendering,O
the,O
risk,O
of,O
transmitting,O
the,O
virus,O
to,O
caregivers,O
through,O
indirect,O
contact,O
with,O
fomites,O
[,O
6,NUMBER
],O
.,O
This,O
finding,O
rein,O
‐,O
forces,O
the,O
need,O
for,O
caregivers,O
of,O
children,O
to,O
practice,O
hand,O
hy,O
‐,O
giene,O
as,O
recommended,O
by,O
the,O
WHO,O
.,O
Second,ORDINAL
.,O
persistent,O
shedding,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
in,O
stools,O
of,O
infected,O
children,O
raises,O
the,O
possibility,O
of,O
faeco,O
‐,O
oral,O
transmission,O
.,O
This,O
potential,O
is,O
evidenced,O
by,O
at,O
least,O
three,NUMBER
studies,O
.,O
which,O
demonstrated,O
that,O
SARS,O
‐,O
CoV,O
‐,O
2,DATE
may,DATE
be,O
present,DATE
in,O
the,O
gastrointestinal,O
tract,O
for,O
a,O
longer,O
duration,O
than,O
viral,O
presence,O
in,O
the,O
respiratory,O
system,O
[,O
7,NUMBER
‐,O
9,NUMBER
],O
.,O
Findings,O
from,O
these,O
studies,O
suggest,O
that,O
paediatric,O
patients,O
discharged,O
on,O
the,O
basis,O
of,O
a,O
negative,O
respiratory,O
test,O
may,O
remain,O
a,O
potential,O
source,O
of,O
viral,O
transmission,O
and,O
indicate,O
that,O
further,O
precau,O
‐,O
tions,O
may,O
need,O
to,O
be,O
taken,O
to,O
avoid,O
secondary,O
infection,CAUSE_OF_DEATH
during,O
the,O
convalescent,O
phase,O
.,O
Third,ORDINAL
.,O
several,O
studies,O
reporting,O
that,O
children,O
are,O
more,O
likely,O
to,O
be,O
asymptomatic,O
or,O
mild,O
symptomatic,O
carriers,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
lead,O
to,O
the,O
concern,O
that,O
children,O
may,O
transmit,O
the,O
virus,O
to,O
other,O
groups,O
covertly,O
[,O
2.3,NUMBER
],O
.,O
The,O
possibili,O
‐,O
ty,O
of,O
asymptomatic,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
has,O
been,O
reported,O
in,O
adults,O
by,O
several,O
studies,O
[,O
20,NUMBER
.,O
21,NUMBER
],O
.,O
while,O
studies,O
specifically,O
targeting,O
the,O
infectiousness,O
of,O
asymptomatic,O
children,O
are,O
yet,O
to,O
be,O
carried,O
out,O
.,O
Future,DATE
studies,O
aiming,O
to,O
understand,O
childrens,O
contribution,O
to,O
asymptomatic,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
should,O
be,O
given,O
priority,O
.,O
as,O
this,O
will,O
influence,O
the,O
balance,O
of,O
control,O
measures,O
for,O
identification,O
and,O
isolation,O
of,O
children,O
and,O
for,O
tracing,O
and,O
quarantining,O
close,O
contacts,O
.,O
infecting,O
other,O
pupils,O
or,O
staff,O
members,O
[,O
12,NUMBER
],O
.,O
Data,O
from,O
both,O
virus,O
and,O
antibody,O
testing,O
suggest,O
that,O
there,O
is,O
limited,O
evidence,O
to,O
suggest,O
significant,O
spread,O
among,O
children,O
and,O
from,O
children,O
to,O
adults,O
.,O
This,O
is,O
con,O
‐,O
sistent,O
with,O
studies,O
showing,O
the,O
majority,O
of,O
infected,O
children,O
are,O
related,O
to,O
family,O
‐,O
cluster,O
outbreaks,O
and,O
showing,O
low,O
rates,O
of,O
infection,CAUSE_OF_DEATH
in,O
children,O
[,O
3.23,NUMBER
],O
.,O
Understanding,O
the,O
proportion,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
infection,CAUSE_OF_DEATH
in,O
children,O
will,O
help,O
to,O
determine,O
childrens,O
relative,O
contribution,O
to,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
transmission,O
in,O
the,O
communi,O
‐,O
ty,O
.,O
Based,O
on,O
the,O
infection,CAUSE_OF_DEATH
rates,O
reported,O
from,O
Iceland,COUNTRY
.,O
Italy,COUNTRY
.,O
South,COUNTRY
Korea,COUNTRY
.,O
Netherlands,COUNTRY
.,O
and,O
US,COUNTRY
[,O
13,NUMBER
‐,O
17,NUMBER
],O
.,O
it,O
seems,O
increasingly,O
likely,O
that,O
there,O
are,O
comparatively,O
fewer,O
children,O
with,O
COVID,O
‐,O
19,NUMBER
in,O
the,O
community,O
.,O
particularly,O
younger,O
children,O
under,O
the,O
age,O
of,O
10,NUMBER
.,O
Data,O
from,O
these,O
studies,O
confirm,O
that,O
the,O
percentage,O
of,O
chil,O
‐,O
dren,O
among,O
the,O
confirmed,O
COVID,O
‐,O
19,NUMBER
patients,O
is,O
small,O
.,O
varying,O
from,O
1,PERCENT
%,PERCENT
in,O
young,O
children,O
up,O
to,O
6,PERCENT
%,PERCENT
in,O
older,O
children,O
.,O
It,O
should,O
be,O
noted,O
that,O
these,O
studies,O
are,O
limited,O
by,O
the,O
small,O
numbers,O
of,O
children,O
tested,O
and,O
the,O
potential,O
of,O
biased,O
non,O
‐,O
random,O
sampling,O
.,O
Better,O
seroprevalence,O
studies,O
are,O
therefore,O
needed,O
to,O
understand,O
whether,O
infection,CAUSE_OF_DEATH
rates,O
in,O
the,O
community,O
are,O
truly,O
lower,O
among,O
children,O
.,O
The,O
reason,O
why,O
COVID,O
‐,O
19,NUMBER
seems,O
to,O
affect,O
children,O
less,O
often,O
and,O
less,O
severely,O
than,O
adults,O
is,O
not,O
yet,O
fully,O
understood,O
.,O
but,O
it,O
could,O
lower,O
chance,O
of,O
exposure,O
.,O
children,O
are,O
unlikely,O
to,O
have,O
been,O
significant,O
drivers,O
of,O
the,O
epidemic,O
so,O
far,O
.,O
and,O
there,O
is,O
not,O
any,O
evidence,O
yet,O
to,O
indicate,O
they,O
are,O
at,O
higher,O
risk,O
of,O
causing,O
super,O
‐,O
spreading,O
events,O
in,O
the,O
community,O
.,O
June,DATE
2020,DATE
Vol,O
.,O
10,NUMBER
No,O
.,O
1,NUMBER
011101,NUMBER
closures,O
and,O
re,O
‐,O
openings,O
.,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
.,O
many,O
countries,O
have,O
taken,O
precautionary,O
Taiwan,COUNTRY
(,O
Febru,O
‐,O
ary,O
),O
.,O
Denmark,COUNTRY
(,O
April,DATE
),O
.,O
Norway,COUNTRY
(,O
April,DATE
),O
.,O
China,COUNTRY
(,O
May,DATE
),O
.,O
France,COUNTRY
(,O
May,DATE
),O
and,O
Germany,COUNTRY
(,O
May,DATE
),O
.,O
Children,O
are,O
less,O
likely,O
to,O
suffer,O
severe,O
and,O
critical,O
COVID,O
‐,O
19,NUMBER
disease,CAUSE_OF_DEATH
than,O
adults,O
[,O
24,NUMBER
],O
.,O
however,O
.,O
a,O
new,O
paedi,O
‐,O
atric,O
multisystem,O
inflammatory,O
syndrome,O
associated,O
with,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
epidemic,O
has,O
recently,DATE
been,O
identified,O
in,O
the,O
UK,COUNTRY
.,O
the,O
US,COUNTRY
.,O
France,COUNTRY
.,O
Italy,COUNTRY
.,O
Spain,COUNTRY
and,O
Switzerland,COUNTRY
.,O
A,O
small,O
number,O
of,O
children,O
with,O
diagnosed,O
COVID,O
‐,O
19,NUMBER
developed,O
a,O
significant,O
systemic,O
inflam,O
‐,O
matory,O
response,O
with,O
a,O
higher,O
rate,O
of,O
cardiac,O
involvement,O
.,O
caused,O
by,O
a,O
severe,O
form,O
of,O
Kawasaki,O
‐,O
like,O
disease,CAUSE_OF_DEATH
[,O
25,NUMBER
],O
.,O
This,O
condition,O
could,O
be,O
fatal,O
and,O
requires,O
prompt,O
and,O
aggressive,O
medical,O
inter,O
‐,O
ventions,O
.,O
This,O
has,O
triggered,O
the,O
release,O
of,O
a,O
new,O
guidance,O
from,O
the,O
Royal,ORGANIZATION
College,ORGANIZATION
of,ORGANIZATION
Paediatrics,ORGANIZATION
and,ORGANIZATION
Child,ORGANIZATION
Health,ORGANIZATION
[,O
26,NUMBER
],O
.,O
Research,O
on,O
this,O
topic,O
is,O
currently,DATE
ongoing,O
(,O
DIAMONDS,O
.,O
ISARIC,O
),O
and,O
a,O
new,O
study,O
from,O
the,O
British,ORGANIZATION
Paediatric,ORGANIZATION
Surveillance,ORGANIZATION
Unit,ORGANIZATION
will,O
be,O
launching,O
soon,O
.,O
performed,O
quality,O
assessment,O
for,O
the,O
included,O
studies,O
.,O
so,O
this,DATE
may,DATE
have,O
biased,O
the,O
results,O
.,O
Many,O
of,O
the,O
not,O
re,O
‐,O
place,O
individual,O
clinical,O
judgement,O
and,O
the,O
sources,O
cited,O
should,O
be,O
checked,O
.,O
The,O
views,O
expressed,O
There,O
is,O
very,O
limited,O
evidence,O
on,O
paediatric,O
cases,O
acting,O
as,O
a,O
source,O
of,O
infection,CAUSE_OF_DEATH
.,O
which,O
high,O
‐,O
lights,O
the,O
importance,O
of,O
obtaining,O
robust,O
data,O
on,O
transmission,O
dynamics,O
in,O
children,O
in,O
future,DATE
studies,O
.,O
Preliminary,O
infected,O
or,O
infect,O
others,O
.,O
Further,O
seroprevalence,O
studies,O
(,O
powered,O
adequately,O
for,O
the,O
paediatric,O
population,O
),O
.,O
are,O
urgently,O
required,O
to,O
estab,O
‐,O
lish,O
whether,O
children,O
are,O
in,O
fact,O
less,O
likely,O
to,O
be,O
infected,O
com,O
‐,O
pared,O
to,O
adults,O
.,O
Faeco,O
‐,O
oral,O
transmission,O
appears,O
to,O
pose,O
a,O
higher,O
risk,O
of,O
onward,O
transmission,O
in,O
infected,O
children,O
compared,O
to,O
adults,O
.,O
given,O
the,O
longer,O
faecal,O
shedding,O
time,O
observed,O
in,O
several,O
studies,O
.,O
This,DATE
may,DATE
have,O
a,O
high,O
level,O
of,O
basic,O
hygiene,O
measures,O
in,O
these,O
settings,O
to,O
limit,O
spread,O
.,O
Funding,O
:,O
ET,O
is,O
supported,O
by,O
a,O
Cancer,ORGANIZATION
Research,ORGANIZATION
UK,ORGANIZATION
Career,ORGANIZATION
Development,ORGANIZATION
Fellowship,ORGANIZATION
(,O
C31250,O
/,O
A22804,O
),O
.,O
AK,STATE_OR_PROVINCE
is,O
supported,O
by,O
a,O
Wellcome,O
Trust,O
Clinical,O
PhD,O
Programme,O
Fel,O
‐,O
lowship,O
with,O
grant,O
reference,O
:,O
203919,NUMBER
/,O
Z,O
/,O
16,NUMBER
/,O
Z.,O
Additional,O
material,O
June,DATE
2020,DATE
Vol.,O
10,NUMBER
No.,O
1,NUMBER
011101,NUMBER
RESEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
OF,O
COVID,O
‐,O
19,NUMBER
EVIDENCE,O
Children,O
and,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
OF,O
COVID,O
‐,O
19,NUMBER
EVIDENCE,O
RESEARCH,O
THEME,O
7,NUMBER
:,O
RAPID,O
REVIEWS,O
Li,O
et,O
al,O
.,O
1,NUMBER
Cruz,PERSON
AT,O
.,O
Zeichner,PERSON
S.,O
COVID,O
‐,O
19,NUMBER
in,O
children,O
:,O
Initial,O
characteriza,O
‐,O
tion,O
of,O
the,O
pediatric,O
disease,CAUSE_OF_DEATH
.,O
Pediatrics,O
.,O
2020,DATE
;,O
145,NUMBER
:,O
e20200834,O
.,O
2,NUMBER
Qiu,PERSON
H,PERSON
.,O
Wu,PERSON
J,PERSON
.,O
Hong,CITY
L,LOCATION
.,O
Luo,O
Y,O
.,O
Song,O
Q,O
.,O
Chen,PERSON
D.,PERSON
Clinical,PERSON
and,O
epidemi,O
‐,O
ological,O
features,O
of,O
36,NUMBER
children,O
with,O
coronavirus,O
3,NUMBER
Dong,O
Y,O
.,O
Mo,PERSON
X,PERSON
.,O
Hu,O
Y,O
.,O
Qi,PERSON
X,PERSON
.,O
Jiang,PERSON
F,O
.,O
Jiang,PERSON
Z,O
.,O
et,O
al,O
.,O
Epidemiology,O
of,O
COVID,O
‐,O
19,NUMBER
Among,O
Children,O
in,O
China,COUNTRY
.,O
Pediatrics,O
.,O
4,NUMBER
Cai,PERSON
J,PERSON
.,O
Xu,PERSON
J,PERSON
.,O
Lin,PERSON
D,O
.,O
Yang,PERSON
Z,O
.,O
Xu,PERSON
L,PERSON
.,O
Qu,O
Z,O
.,O
Zhang,O
Y,O
.,O
et,O
al,O
.,O
A,O
Case,O
Series,O
of,O
children,O
with,O
2019,DATE
novel,O
coronavirus,O
infection,CAUSE_OF_DEATH
:,O
public_26,PERCENT
%,PERCENT
20April,PERCENT
%,PERCENT
202020.pdf,O
.,O
Accessed,O
:,O
26,DATE
April,DATE
2020,DATE
.,O
6,NUMBER
Yung,PERSON
CF,PERSON
.,O
Kam,PERSON
K,PERSON
.,O
Wong,PERSON
M,O
.,O
Maiwald,PERSON
M,O
.,O
Tan,MISC
Y,O
.,O
Tan,O
B,O
.,O
et,O
al,O
.,O
Environment,O
and,O
Personal,O
Protective,O
Equip,O
‐,O
ment,O
Tests,O
for,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
in,O
the,O
Isolation,O
Room,O
of,O
an,O
Infant,O
With,O
Infection,CAUSE_OF_DEATH
.,O
Ann,O
Intern,TITLE
Med,O
.,O
2020,DATE
;,O
M20,O
‐,O
0942,DATE
.,O
Medline,O
:,O
32236490,NUMBER
8,NUMBER
Ma,O
X,O
.,O
Su,PERSON
L,PERSON
.,O
Zhang,O
Y,O
.,O
Zhang,PERSON
X,PERSON
.,O
Gai,O
Z,O
.,O
Zhang,O
Z.,O
Do,O
children,O
need,O
a,O
longer,O
time,O
to,O
shed,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
in,O
stool,O
than,O
adults,O
?,O
erry,O
C,O
.,O
Barbara,PERSON
M,PERSON
.,O
Talitha,PERSON
V,PERSON
.,O
Marta,PERSON
Z,PERSON
.,O
Jorg,PERSON
H,PERSON
.,O
Angela,PERSON
S,PERSON
.,O
et,O
al,O
.,O
An,O
analysis,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
viral,O
load,O
by,O
patient,O
age,O
.,O
1134v1,O
?,O
ver,O
‐,O
sioned,O
=,O
TRUE,O
.,O
Accessed,O
:,O
5,DATE
May,DATE
2020,DATE
.,O
anis,O
K,O
.,O
Epaulard,PERSON
O,PERSON
.,O
Bnet,O
T,O
.,O
Gaymard,PERSON
A,O
.,O
Campoy,PERSON
S,O
.,O
Botelho,PERSON
‐,O
Nevers,O
E,O
.,O
et,O
al,O
.,O
Cluster,O
of,O
Coronavirus,O
Disease,CAUSE_OF_DEATH
2019,DATE
14,NUMBER
Lavezzo,PERSON
E,O
.,O
Franchin,O
E,O
.,O
Ciavarella,PERSON
C,O
.,O
Cuomo,PERSON
‐,O
Dannenburg,O
G,O
.,O
Barzon,PERSON
L,PERSON
.,O
Del,STATE_OR_PROVINCE
Vec,O
‐,O
chio,O
C,O
.,O
et,O
al,O
.,O
Suppression,O
of,O
COVID,O
‐,O
19,NUMBER
15,NUMBER
COVID,O
‐,O
19,NUMBER
National,O
Emer,O
‐,O
gency,O
Response,O
Center,O
.,O
Epidemiology,O
and,O
Case,O
Management,O
Team,O
.,O
Ko,O
‐,O
rea,O
Centers,O
for,O
Disease,CAUSE_OF_DEATH
3v2,NUMBER
?,O
versioned,O
=,O
TRUE,O
.,O
Accessed,O
:,O
5,DATE
May,DATE
2020,DATE
.,O
18,NUMBER
Docherty,O
A,O
.,O
Harrison,PERSON
E,O
.,O
Green,ORGANIZATION
C,ORGANIZATION
.,O
Hardwick,PERSON
H,O
.,O
Pius,PERSON
R,PERSON
.,O
Norman,PERSON
L,PERSON
.,O
et,O
al,O
.,O
Features,O
of,O
16.749,NUMBER
hospitalised,O
UK,COUNTRY
patients,O
with,O
org,O
/,O
con,O
‐,O
tent,O
/,O
10.1101,NUMBER
/,O
2020.04.23.20076042,NUMBER
v1?versioned,O
=,O
TRUE,O
.,O
Accessed,O
:,O
5,NUMBER
May,DATE
2020,DATE
.,O
20,NUMBER
Kimball,PERSON
A,O
.,O
Hatfield,PERSON
K,PERSON
.,O
Arons,PERSON
M,O
.,O
James,PERSON
A,PERSON
.,O
Taylor,PERSON
J,PERSON
.,O
Spicer,PERSON
K,PERSON
.,O
et,O
al,O
.,O
Asymptomatic,O
and,O
Presymptomatic,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
In,O
‐,O
fections,O
in,O
Residents,O
of,O
a,O
long,O
‐,O
term,O
care,O
skilled,O
nursing,O
facili,O
‐,O
ty,O
King,TITLE
County,O
.,O
Washington,STATE_OR_PROVINCE
.,O
March,DATE
2020,DATE
.,O
MMWR,O
Morb,O
21,NUMBER
Wei,O
WE,O
.,O
Li,PERSON
Z,O
.,O
Chiew,PERSON
C,PERSON
.,O
Yong,PERSON
S,PERSON
.,O
Toh,PERSON
M,O
.,O
Lee,PERSON
V.,PERSON
Presymptomatic,PERSON
Transmission,PERSON
of,PERSON
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
Singapore,COUNTRY
.,O
January,DATE
23,DATE
ang,O
Y,O
.,O
Wang,PERSON
X,PERSON
.,O
Yang,O
Y,O
.,O
Liu,PERSON
Y,PERSON
.,O
Liu,PERSON
L.,PERSON
Epidemiological,PERSON
and,O
clini,O
‐,O
cal,O
characteristics,O
analysis,O
of,O
30,NUMBER
childhood,O
cases,O
with,O
2019,DATE
nov,DATE
‐,O
el,O
coronavirus,O
infection,CAUSE_OF_DEATH
in,O
Shenzhen,CITY
.,O
Chin,PERSON
J,PERSON
Inf,PERSON
Dis,PERSON
.,O
2020,DATE
.,O
25,NUMBER
Verdoni,O
L,O
.,O
Mazza,PERSON
A,O
.,O
Gervasoni,PERSON
A,O
.,O
Martelli,PERSON
L,O
.,O
Ruggeri,PERSON
M,O
.,O
Ciuffreda,PERSON
M,O
.,O
et,O
al,O
.,O
An,O
outbreak,O
of,O
severe,O
Kawasaki,ORGANIZATION
‐,O
like,O
disease,CAUSE_OF_DEATH
26,NUMBER
Royal,O
College,ORGANIZATION
of,ORGANIZATION
Paediatrics,ORGANIZATION
and,ORGANIZATION
Child,ORGANIZATION
Health,ORGANIZATION
.,O
Guidance,O
:,O
Paediatric,O
multisystem,O
inflammatory,O
syndrome,O
temporally,O
June,DATE
2020,DATE
Vol.,O
10,NUMBER
No.,O
1,NUMBER
011101,NUMBER
